Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases

Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

(2014) Dai Kishida et al.   Modern Rheumatology

Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis

(2010) Daichi Inoue et al.   CLINICAL RHEUMATOLOGY

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

(2009) S Nishida et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis

(2009) Hiroe Sato et al.   CLINICAL RHEUMATOLOGY

Effective Anti-TNF-  Therapy Can Induce Rapid Resolution and Sustained Decrease of Gastroduodenal Mucosal Amyloid Deposits in Reactive Amyloidosis Associated with Rheumatoid Arthritis

(2009) T. KURODA et al.   JOURNAL OF RHEUMATOLOGY